H. Pylori Infection
Pipeline by Development Stage
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (8)
Total enrollment: 1,112 patients across 8 trials
Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community-AIM 2
A Randomized, Double-Blind, Multicenter Study to Evaluate the Acid-inhibitory and Dose-response Efficacy of TAK-438 (20 mg, 40 mg) in Patients With Proton Pump Inhibitor (PPI) - Resistant Erosive Esophagitis
A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Low-Dose Aspirin Therapy
A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Non-Steroid Anti-Inflammatory Drug (NSAID) Therapy
Efficacy of TAK-438, Amoxicillin and Clarithromycin in the First Line Eradication of H. Pylori
Long-Term Safety Study of TAK-438 in the Maintenance Treatment of Healed Erosive Esophagitis
A Bioequivalence (BE) Study of TAK-438 Orally Disintegrating (OD) Tablet
A Pharmacokinetic Study of TAK-438 in Healthy Adult Chinese Participants